OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of $918.47 million. The enterprise value is $974.57 million.
Important Dates
The last earnings date was Tuesday, April 28, 2026, after market close.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OPKO Health has 759.07 million shares outstanding. The number of shares has increased by 12.81% in one year.
| Current Share Class | 759.07M |
| Shares Outstanding | 759.07M |
| Shares Change (YoY) | +12.81% |
| Shares Change (QoQ) | -0.87% |
| Owned by Insiders (%) | 42.52% |
| Owned by Institutions (%) | 25.72% |
| Float | 336.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.59 |
| Forward PS | 1.68 |
| PB Ratio | 0.73 |
| P/TBV Ratio | 29.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.32.
| Current Ratio | 3.61 |
| Quick Ratio | 2.84 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.95 |
Financial Efficiency
Return on equity (ROE) is -16.92% and return on invested capital (ROIC) is -15.89%.
| Return on Equity (ROE) | -16.92% |
| Return on Assets (ROA) | -6.36% |
| Return on Invested Capital (ROIC) | -15.89% |
| Return on Capital Employed (ROCE) | -11.87% |
| Weighted Average Cost of Capital (WACC) | 14.99% |
| Revenue Per Employee | $255,439 |
| Profits Per Employee | -$93,589 |
| Employee Count | 2,275 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 7.73 |
Taxes
| Income Tax | -16.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.18% in the last 52 weeks. The beta is 1.49, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | -14.18% |
| 50-Day Moving Average | 1.18 |
| 200-Day Moving Average | 1.32 |
| Relative Strength Index (RSI) | 53.49 |
| Average Volume (20 Days) | 1,904,945 |
Short Selling Information
The latest short interest is 32.98 million, so 4.34% of the outstanding shares have been sold short.
| Short Interest | 32.98M |
| Short Previous Month | 33.62M |
| Short % of Shares Out | 4.34% |
| Short % of Float | 9.81% |
| Short Ratio (days to cover) | 13.00 |
Income Statement
In the last 12 months, OPKO Health had revenue of $581.12 million and -$212.92 million in losses. Loss per share was -$0.28.
| Revenue | 581.12M |
| Gross Profit | 85.04M |
| Operating Income | -202.83M |
| Pretax Income | -228.97M |
| Net Income | -212.92M |
| EBITDA | -112.49M |
| EBIT | -202.83M |
| Loss Per Share | -$0.28 |
Full Income StatementBalance Sheet
The company has $341.88 million in cash and $390.39 million in debt, giving a net cash position of -$48.51 million or -$0.06 per share.
| Cash & Cash Equivalents | 341.88M |
| Total Debt | 390.39M |
| Net Cash | -48.51M |
| Net Cash Per Share | -$0.06 |
| Equity (Book Value) | 1.20B |
| Book Value Per Share | 1.60 |
| Working Capital | 386.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$163.30 million and capital expenditures -$10.92 million, giving a free cash flow of -$174.22 million.
| Operating Cash Flow | -163.30M |
| Capital Expenditures | -10.92M |
| Depreciation & Amortization | 90.34M |
| Net Borrowing | -67.04M |
| Free Cash Flow | -174.22M |
| FCF Per Share | -$0.23 |
Full Cash Flow StatementMargins
Gross margin is 14.63%, with operating and profit margins of -34.90% and -36.64%.
| Gross Margin | 14.63% |
| Operating Margin | -34.90% |
| Pretax Margin | -39.40% |
| Profit Margin | -36.64% |
| EBITDA Margin | -19.36% |
| EBIT Margin | -34.90% |
| FCF Margin | n/a |